Clinical Trial Update: A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Participants With Prader-Willi Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial assessing long-term safety of pharmaceutical grade synthetic cannabidiol oral solution in Prader-Willi syndrome was terminated; results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• pharmaceutical grade synthetic cannabidiol oral solution (cannabidiol)

Snippet

Sponsor: Radius Pharmaceuticals, Inc. | Conditions: Prader-Willi Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2023-06-22